Yingjie Qiu, M.S., Ph.D. Titles and Appointments Assistant Professor School School of Public Health Department Public Health | Harold C. Simmons Comprehensive Cancer Center Biography As a statistician in biomedical research, I specialize in developing innovative trial designs, methods, and tools for complex data analysis and decision-making. My expertise lies in Bayesian adaptive clinical trials, survival and longitudinal data analysis, and bioinformatics. Education Ph.D. in Biostatistics (Ph.D. Minor in Bioinformatics). Indiana University. Education Graduate School (2020), Biostatistics Research Interest Adaptive clinical trial designs Biostatistics Early phase clinical trial design Longitudinal Data Analysis Maternal Health Single-cell sequencing and spatial transcriptomics Statistical methods for cancer research Survival analysis Publications Featured Publications A robust Bayesian dose optimization design with backfill and randomization for phase I/II clinical trials. Qiu Y, Li M, Stat Methods Med Res 2025 Sep 9622802251374290 A randomized Bayesian phase I-II dose optimization design for combination cancer therapies with progression-free survival end point. Qiu Y, Li M, BMC Med Res Methodol 2025 Sep 25 1 214 A model-free phase I/II dose optimization design for immunotherapy trials. Qiu Y, Lu M, Han Y, Zhou W, Zhao Y, Han L, Zang Y, Stat Methods Med Res 2025 May 9622802251340246 UNITED: A Unified Transparent and Efficient Phase I/II Trial Design for Dose Optimization Accounting for Ordinal Graded, Continuous and Mixed Toxicity and Efficacy Endpoints. Li M, Guo Z, Qiu Y, Stat Med 2025 May 44 10-12 e70098 Great Wall: A Generalized Dose Optimization Design for Drug Combination Trials Maximizing Survival Benefit. Han Y, Qiu Y, Zhao Y, Wan I, Li L, Liu S, Zang Y, Pharm Stat 2025 24 6 e70049 A Generalized Model Free Framework for Dose Optimization in Multiple-dose Randomized Early Phase Clinical Trials Qiu, Y., Liu, F., Zhao, Q. et al. Statistics in Biosciences 2025 Adaptive phase I-II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapies. Zang Y, Guo B, Qiu Y, Liu H, Opyrchal M, Lu X, Clin Trials 2024 Jun 21 3 298-307 A Bayesian Dynamic Model-Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials Yingjie Qiu, Mingyue Li Pharmaceutical Statistics 2024 Modified isotonic regression based phase I/II clinical trial design identifying optimal biological dose. Qiu Y, Zhao Y, Liu H, Cao S, Zhang C, Zang Y, Contemp Clin Trials 2023 Apr 127 107139 A Bayesian Dynamic Model-Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials. Qiu Y, Li M, Pharm Stat 2024 Nov Results 1-10 of 17 1 2 Next Last Honors & Awards Delta Omega Honorary Society in Public HealthBeta Zeta chapter (2024) Indiana University Graduate School Indianapolis Chancellor's ScholarSelect one student enrolled in a Ph.D. Program (2024) Travel AwardOral presentation at Statistical Practice in Cancer Conference (2024) Best Poster Award for Student CompetitionIndiana University Center for Computational Biology and Bioinformatics (CCBB) Annual Retreat (2023)
